Combination of hydralazine and all-trans retinoic acid targeting breast cancer cells. [PDF]
Yahyapour A, Askari N, Yaghoobi MM.
europepmc +1 more source
Hydralazine-Induced Diarrhea in a Geriatric Patient: A Case Report and a Review of the Literature on Deprescribing as a Diagnostic Strategy. [PDF]
Hussain A, Sprei M, Moradi L.
europepmc +1 more source
Use of Intravenous Clevidipine in the Management of Severe Preeclampsia: A Case Report. [PDF]
Brazeal C, Shapiro A.
europepmc +1 more source
Reducing the Nonindicated Use of IV Hydralazine in the Inpatient Setting. [PDF]
Kumar A, Lynch J, Baldwin J.
europepmc +1 more source
Retiform purpura in a patient with iododerma and atypical perinuclear antineutrophil cytoplasmic antibody. [PDF]
Vigil SR +4 more
europepmc +1 more source
Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy. [PDF]
Eadon MT +18 more
europepmc +1 more source
Hypertension and heart failure: Navigating blood pressure targets and medication titration and tolerance. [PDF]
Helmy I, Karnib M, Sundaram V.
europepmc +1 more source
Cerebral Sympathetic Nervous System Activation Promotes Intrarenal Renin-Angiotensin System Activity and Salt-Induced Nocturnal Polyuria. [PDF]
Tsujimura G +13 more
europepmc +1 more source
The change in the pharmacological significance of dihydralazine (Germany) and hydralazine (USA). [PDF]
Mech C, Seifert R.
europepmc +1 more source
Hydralazine-Induced ANCA-Associated Vasculitis With Lupus Nephritis Features and a Unique Antibody Profile. [PDF]
Rabie M, Scalise M.
europepmc +1 more source

